Symptom Clusters in Children With Leukemia

Clinical Trial Description

A repeated measures research design will evaluate phenotypic and genotypic treatment-related symptom associations experienced by children and adolescents 3-17 years of age with a diagnosis of leukemia. ;

Study Design

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT03336931` - PRecISion Medicine for Children With Cancer
	Recruiting	`NCT04478006` - Advanced Translational Research on Childhood Leukemia
	Recruiting	`NCT05504772` - Precision Medicine for Every Child With Cancer

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT03336931 - PRecISion Medicine for Children With Cancer

Recruiting

NCT04478006 - Advanced Translational Research on Childhood Leukemia

Recruiting

NCT05504772 - Precision Medicine for Every Child With Cancer

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01708421
Study type	Observational
Source	Duke University
Contact
Status	Completed
Phase
Start date	November 2012
Completion date	August 1, 2018

Symptom Clusters in Children With Leukemia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms